Mymd Pharmaceuticals Inc (MYMD)

Mymd Pharmaceuticals Inc Azioni (MYMD) Dati Finanziari

Conto economico

Trimestrale

*Tutti i numeri sono espressi in milioni

Data di fine periodo	2024-03-31	2023-12-31	2023-09-30	2023-06-30	2023-03-31
Durata del periodo	3 mesi	3 mesi	3 mesi	3 mesi	3 mesi
Research and Development	59.50% 1.1989	2.9606	1.9123	2.2244	0.7704
Operating Income/Loss	43.27% -2.7846	-4.9085	-3.8426	-5.7816	-2.5903
Nonoperating Income/Loss	375.66% -7.0154	2.545	7.8856	1.614	1.0786
Income/Loss From Continuing Operations Before Tax	314.63% -9.80	-2.3636	4.043	-4.1677	-1.5117
Income/Loss From Continuing Operations After Tax	50.94% -9.80	-6.4926	4.043	-4.1677	-1.5117
Net Income/Loss	314.63% -9.80	-2.3636	4.043	-4.1677	-1.5117
Preferred Stock Dividends And Other Adjustments	52.46% 1.2019	2.528	1.1581	-	-
Attributable To Noncontrolling Interest	-	-	-	-	-
Basic Average Shares	105.33% 2.1411	-40.17	44.95	40.35	39.79
Basic Earnings Per Share	2.10% -5.14	-5.25	0.06	-0.11	-0.04
Diluted Earnings Per Share	2.10% -5.14	-5.25	0.06	-0.11	-0.05
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic	52.46% 1.2019	2.528	1.1581	-	-